Legend Biotech CorpLEGNEarnings & Financial Report
GenScript Biotech, fully known as GenScript Biotech Corporation, usually referred to as simply GenScript, is a China–based biotech company. It was co-founded in 2002 in New Jersey by Fangliang Zhang, Ye Wang, and Luquan Wang. The company mainly provides life science research application instruments and services. It was listed on the Hong Kong Stock Exchange in 2015. The current rotating CEO of the firm is Shao Weihui, who also served as the chief operating officer and Chinese Communist Party ...
LEGN Q3 2025 Key Financial Metrics
Revenue
$272.3M
Gross Profit
$159.1M
Operating Profit
$-43.5M
Net Profit
$-39.7M
Gross Margin
58.4%
Operating Margin
-16.0%
Net Margin
-14.6%
YoY Growth
70.0%
EPS
$-0.11
Financial Flow
Legend Biotech Corp Q3 2025 Financial Summary
Legend Biotech Corp reported revenue of $272.3M for Q3 2025, with a net profit of $-39.7M (-14.6% margin). Cost of goods sold was $113.3M, operating expenses totaled $202.5M.
Key Financial Metrics
| Total Revenue | $272.3M |
|---|---|
| Net Profit | $-39.7M |
| Gross Margin | 58.4% |
| Operating Margin | -16.0% |
| Report Period | Q3 2025 |
Income Statement
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $73.3M | $96.0M | $94.0M | $186.5M | $160.2M | $195.1M | $255.1M | $272.3M |
| YoY Growth | N/A | N/A | 158.7% | 154.4% | 66.9% | 107.5% | 36.7% | 70.0% |
Balance Sheet
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.93B | $1.84B | $1.78B | $1.80B | $1.74B | $1.62B | $1.69B | $1.71B |
| Liabilities | $523.6M | $499.7M | $611.0M | $639.2M | $619.7M | $597.9M | $654.4M | $701.7M |
| Equity | $1.41B | $1.34B | $1.16B | $1.16B | $1.12B | $1.02B | $1.04B | $1.01B |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-97.6M | $-60.8M | $15.5M | $-1.7M | $-75.8M | $-103.8M | $-13.0M | $28.8M |
